大医药板块回升，金迪克涨超15%

Core Viewpoint - The pharmaceutical sector experienced a rebound on November 11, with significant gains in various sub-sectors including chemical pharmaceuticals, innovative drugs, weight loss drugs, and recombinant proteins [2] Group 1: Sector Performance - The chemical pharmaceutical sector showed strong performance, contributing to the overall recovery of the pharmaceutical industry [2] - Innovative drugs also saw notable increases, indicating a positive market sentiment towards new drug developments [2] - Weight loss drugs and recombinant proteins were among the top gainers, reflecting growing consumer interest and demand in these areas [2] Group 2: Individual Stock Movements - Gendik rose over 15%, highlighting its strong market performance within the sector [2] - Hongyuan Pharmaceutical increased by more than 7%, indicating investor confidence in its growth prospects [2] - Other companies such as Nanjing New Pharmaceutical, Hendi Pharmaceutical, Haichen Pharmaceutical, and Tailong Pharmaceutical also experienced upward movements, suggesting a broader trend of recovery among pharmaceutical stocks [2]